Evidence Solutions
A flexible approach to real-world evidence generation
Whether you're tackling bold research questions or time-critical decision points along the way, Flatiron’s Evidence Solutions are flexible to deliver the data and clinical, analytical and regulatory support you need to achieve your goals faster and more efficiently than ever before.
Industry-leading oncology evidence generation solutions
Flatiron Horizon is the driving force behind our real-world evidence solutions, seamlessly integrating the richest labeled oncology data in the world, Flatiron’s proprietary curation methods and disease-specific ML models, technology, oncology experience, and expertise. It enables swift and efficient curation of data and insights, empowering us to understand the narrative within the data—from patient to evidence.
5M+
de-identified patient records
1.5B+
data points available for research
4
global cancer site networks
5+
years of direct collaboration with FDA, NICE and, other HTA bodies
Tailored oncology evidence solutions for every phase of the biopharma lifecycle
From pre-market to commercial, Flatiron partners with leading life science companies to deliver fit-for-purpose real-world evidence solutions that support oncology portfolios across the development lifecycle.
Our areas of expertise include:
Disclaimer: Non-exhaustive
Industry-leading oncology evidence solutions
Our flexible real-world data configurations are tailored to address the specific needs of your oncology portfolio and now encompass more than 5 million patient journeys, 4 of the largest oncology markets in the world, 22+ tumor types, and multimodal data.
We know real-world data. We deliver oncology real-world evidence. Flatiron’s in-house expertise and flexible engagement models can help you generate the insights and evidence you need to advance your oncology portfolio, from refining target product profiles, to conducting comparative effectiveness studies and supporting regulatory and HTA submissions.
What can Flatiron Horizon do for you?
Learn more about our flexible, tailored solutions and how we can support your oncology evidence generation needs.